Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05231 (
interleukin-6
)
23,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Proteins of the protein tyrosine phosphatase (PTP) family are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, and apoptosis.
PTPN13
(also known as FAP1, PTPL1, PTPLE, PTPBAS, and PTP1E), a putative tumor suppressor, is frequently inactivated in lung carcinoma through the loss of either mRNA or protein expression. However, the molecular mechanisms underlying its dysregulation have not been fully explored.
Interleukin-6
(
IL-6
) mediated Stat3 activation is viewed as crucial for multiple tumor growth and progression. Here, we demonstrate that
PTPN13
is a direct transcriptional target of Stat3 in the squamous cell lung carcinoma. Our data show that
IL-6
administration or transfection of a constitutively activated Stat3 in HCC-1588 and SK-MES-1 cells inhibits
PTPN13
mRNA transcription. Using luciferase reporter and ChIP assays, we show that Stat3 binds to the promoter region of
PTPN13
and promotes its activity through recruiting HDAC5. Thus, our results suggest a previously unknown Stat3-
PTPN13
molecular network controlling squamous cell lung carcinoma development.
...
PMID:Stat3 inhibits PTPN13 expression in squamous cell lung carcinoma through recruitment of HDAC5. 2419 Dec 46